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ABSTRACT
RNA splicing is an important aspect of gene regula-
tion in many organisms. Splicing of RNA is regulated
by complicated mechanisms involving numerous
RNA-binding proteins and the intricate network of
interactions among them. Mutations in cis-acting
splicing elements or its regulatory proteins have
been shown to be involved in human diseases.
Defects in pre-mRNA splicing process have
emerged as a common disease-causing mechan-
ism. Therefore, a database integrating RNA
splicing and disease associations would be helpful
for understanding not only the RNA splicing but also
its contribution to disease. In SpliceDisease
database, we manually curated 2337 splicing
mutation disease entries involving 303 genes and
370 diseases, which have been supported experi-
mentally in 898 publications. The SpliceDisease
database provides information including the
change of the nucleotide in the sequence, the
location of the mutation on the gene, the reference
Pubmed ID and detailed description for the relation-
ship among gene mutations, splicing defects
and diseases. We standardized the names of the
diseases and genes and provided links for these
genes to NCBI and UCSC genome browser for
further annotation and genomic sequences. For
the location of the mutation, we give direct links of
the entry to the respective position/region in the
genome browser. The users can freely browse,
search and download the data in SpliceDisease at
http://cmbi.bjmu.edu.cn/sdisease.
INTRODUCTION
Cells need to regulate the expression of a gene in a
speciﬁc level at speciﬁc time and space in order to fulﬁll
speciﬁc task. Gene regulation is a ubiquitous phenomenon
and is critical in every biological process (1). Mechanisms
of gene regulation include the regulations of transcription,
RNA processing and translation. In higher eukaryotes,
pre-mRNA splicing plays an important role in gene
regulation. The inclusion of different exons in mRNA—
alternative splicing (AS)—enables one single gene to
produce multiple different mRNAs, which can be further
translated into different proteins called splice variants
(2,3). New high-throughput sequencing technology has
revealed that >90% of human genes undergo AS—a
much higher percentage than anticipated (4). And recent
genome-wide analyses have indicated that almost all
primary transcripts from multi-exon human genes
undergo alternative pre-mRNA splicing (5). Therefore,
RNA splicing greatly increases the genomic complexity
of higher eukaryotes (6). RNA splicing is tissue speciﬁc
and studies highlight differences in the types of AS
occurring commonly in different tissues. For example,
the frequencies of alternative 30 splice site and alternative
50 splice site usage are  50–100% higher in liver than in
other investigated tissues (7). The importance of splicing is
emphasized by its presence in species throughout the
phylogenetic tree. Evolutionary studies, which have
revealed the formation of de novo alternative exons and
the evolution of exon–intron architecture, highlight the
importance of AS in the diversiﬁcation of the transcrip-
tome, especially in humans (8).
As we stated earlier, RNA splicing is critical in
many biological processes. Splicing of RNA is regulated
by complicated mechanisms involving numerous RNA-
binding proteins and the intricate network of interactions
among them. Splicing in general, and AS in particular,
if disrupted, can lead to disease. Therefore, mutations in
cis-acting splicing elements or splicing machinery and the
regulatory proteins which could compromise the accuracy
of either constitutive or alternative splicing would have
a profound impact on human pathogenesis. Defects in
pre-mRNA splicing have been shown as a common
disease-causing mechanism in several studies (9–11).
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leads to exon 7 skipping and a truncated protein, which
causes decreased effective rate of SMN protein production
and motor neuron degenerative disease (12). Other studies
indicate trans-acting mutations affect RNA-dependent
functions and cause disease (9,13). A number of bioinfor-
matics resources for RNA splicing have been developed
during the past decade including databases and tools
(Table 1). For example, Human Splicing Finder is a tool
to predict the effects of mutations on splicing signals and
can identify splicing motifs in human sequence (14). These
resources have provided great help in the study and
analysis of RNA splicing.
The above evidences have shown an increased import-
ance of connecting the RNA splicing and diseases.
For this reason, a high quality database linking RNA
splicing and splicing mutations with disease will be of
great help and be emergently needed in the study of
both RNA splicing and disease. Although the human
gene mutation database (HGMD, http://www.hgmd
.org/) integrated this kind of data but there are big differ-
ence between HGMD and SpliceDisease database (15).
Firstly, HGMD is not free and only provides ‘search’
function for registered users for limited days. Secondly,
HGMD only provides information of point mutations of
intronic sequence for splicing mutation. Thirdly, HGMD
does not provide detailed descriptions for the relationship
among gene mutations, splicing defects and diseases.
On the other hand, SpliceDisease database is a free and
comprehensive database containing cis-splicing sequence
mutations and trans-acting splicing mutations that cause
disease. SpliceDisease integrates detailed descriptions for
the relationship among gene mutation, splicing defect and
disease. And it provides direct links of EntreZ gene,
genome browser, respective location of the mutation on
the gene and PubMed for each literature. At present, the
‘SpliceDisease’ database is at its ﬁrst step, it will be a
valuable ongoing resource for the study of RNA splicing
and disease.
DATA SOURCES AND IMPLEMENTATION
RNA splicing and disease-related literature was acquired
by PubMed search using the keywords ‘splice’, ‘splicing’
and ‘spliced’. Literatures with titles including ‘mutation
spectrum’, ‘mutational spectrum’, ‘mutation analysis’
and ‘mutation screening’ were also obtained. We then
curated the data manually and retrieved the association
between RNA splicing and splicing mutations in the gene
and disease of interest. The data were double checked
by different people. We standardized the disease names
and gene names based on NLM Mesh Browser and
Table 1. Databases and tools of splicing mutation and alternative splicing
Resource Description URL
HGMD (15) The Human Gene Mutation Database (HGMD) constitutes
a comprehensive core collection of data on germ-line
mutations in nuclear genes underlying or associated with
human inherited disease
www.hgmd.org
DBASS5 (16,17) A database of aberrant 50 splice sites http://www.dbass.org.uk/
DBASS3 (17,18) A database of aberrant 30 splice sites http://www.dbass.org.uk/
ASDB (19) Database of alternatively spliced genes http://cbcg.nersc.gov/asdb
ssSNPTarget (20) A genome-wide splice-site Single Nucleotide Polymorphism
database
http://ssSNPTarget.org
EuSplice (21) a splice-centric database which provides reliable splice signal
and AS information for 23 eukaryotes
http://66.170.16.154/EuSplice
AsMamDB (22) An alternative splice database of mammals http://166.111.30.65/ASMAMDB.html
Alternative Splicing Database (23) An alternative splicing database based on publications http://cgsigma.cshl.org/new_alt_exon_db2/
TassDB2 (24) A database of subtle alternative splicing events http://www.tassdb.info
ISIS (25) An intron information system http://isis.bit.uq.edu.au/
ASPicDB (26) A database of annotated transcript and protein variants
generated by alternative splicing
http://www.caspur.it/ASPicDB/
STEPs (27) A database of splice translational efﬁciency polymorphisms http://dbstep.genes.org.uk/
Human Splicing Finder (14) A tool to predict the effects of mutations on splicing signals
or to identify splicing motifs in any human sequence
http://www.umd.be/HSF/
SpliceMiner (28) A high-throughput database implementation of the NCBI
Evidence Viewer for microarray splice variant analysis
http://discover.nci.nih.gov/spliceminer
Intronerator (29) Exploring introns and alternative splicing in Caenorhabditis
elegans
http://www.cse.ucsc.edu/ kent/intronerator
WebScipio (30) Tool for Predicting mutually exclusive spliced exons based
on exon length, splice site and reading frame conservation,
and exon sequence homology
http://www.webscipio.org
IsoEM (31) Tool for the estimation of alternative splicing isoform
frequencies from RNA-Seq data
http://dna.engr.uconn.edu/software/IsoEM/
MAISTAS (32) A tool for automatic structural evaluation of alternative
splicing products
http://maistas.bioinformatica.crs4.it/
HMMSplicer (33) A tool for efﬁcient and sensitive discovery of known and
novel splice junctions in RNA-Seq data
http://derisilab.ucsf.edu/software/hmmsplicer
SFmap (34) A web server for motif analysis and prediction of splicing
factor binding sites
http://sfmap.technion.ac.il
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hensive annotations and to UCSC genome browser for
genomic sequence. The mutations of genes were annotated
as well including nucleotide change and location on the
sequence. We used the nomenclature for description of
sequence variants and exon/intron numbering according
to den Dunnen and Antonarakis (35). For example: ‘c.’
for a cDNA sequence; IVS for intron sequence; substitu-
tions are designated by a ‘>’ character. We also gave
direct link for entry to the respective position of
mutation. In the sequence ﬁle, the intron/exon of the
mutation location is highlighted in yellow color and the
speciﬁc nucleotide is marked in red color. PubMed IDs
and hyperlinks to PubMed were also provided for each
literature. More importantly, we curated the detailed de-
scription for the relationship among gene mutation,
splicing defect and disease.
As a result, we manually curated 2337 splicing
mutation-disease entries including 303 genes and 370
diseases from 898 publications. In the 2337 entries,
 89% of them are point mutations (Figure 1A) among
which >50% are mutations between G and A (36.5%
G>A and 14.6% A>G) (Figure 1B).
All data were organized in the ‘SpliceDisease’ database
using PostgreSQL 9.0, a lightweight database manage-
ment system. The website is presented using Apache
Tomcat 7.0, a JSP&Java web framework which is avail-
able at http://cmbi.bjmu.edu.cn/sdisease/.
USING SpliceDisease
SpliceDisease is a user-friendly designed database. The
homepage has been designed to provide an organized
venue to access all data. The top banner section of
the homepage has tabs for ‘Browser’, ‘Search’, ‘Submit’,
‘Download’ and ‘Help’, respectively. When a user
performs a search in SpliceDisease, he can use the
‘Browser’ to select the disease or gene of interest or use
the ‘Search’ which supports fuzzy queries to ﬁnd it.
The page of result contains nine items disease name and
gene symbol, gene EntreZ ID (link to NCBI gene
Figure 2. SpliceDisease results page. (A) Once a user runs a search, there comes the result summary page that includes nine items. (B) The direct link
for entry to the respective position of mutation. The sequence of exon shows in upper case and intron shows in lower case. And one FASTA record
per region (exon, intron) is used in the sequence ﬁle. The inton/exon of the location of mutation is highlighted in yellow color and speciﬁc nucleotide
is marked in red color.
Figure 1. Distribution of mutation type and distribution of point mutation type in the SpliceDisease database. (A) Splicing mutation type: point,
point mutation; ins, insertion mutation; del, deletion mutation; other, other types. (B) Axes of the histogram represent the proportions of different
nucleotide substitutions in whole point mutations.
Nucleic Acids Research, 2012,Vol. 40,Database issue D1057database), chromosome location of genomic sequence
(link to UCSC genome browser), mutation, mutation
location (direct link to respective position of mutation in
the genome browser automatically), organism, description
and reference (link to PubMed database) (Figure 2).
All data in SpliceDisease can be downloaded in a ﬁle of
csv format. These data will facilitate study of exploitation
of splicing mutational mechanisms, understanding of
RNA biology and helping to discover new therapeutic
targets.
FUTURE EXTENSIONS
The SpliceDisease database is in the ﬁrst step of the
project and further extensions will be developed. As we
described earlier, a number of bioinformatics resources for
RNA splicing have been developed. Therefore, we plan to
integrate some related bioinformatics resources in the near
future. We will also incorporate the expression data of
different mRNA isoforms. As the data accumulation, we
will add more trans-acting splicing mutations that cause
disease. Finally, SpliceDisease will be continuously
updated.
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